(PharmaNewsWire.Com, October 31, 2017 ) Hemophilia is an inherited bleeding disorder. The gene responsible for hemophilia is present on the X chromosome and is inherited in a recessive manner. Hemophilia A, also called as factor VIII (FVIII) deficiency or classic hemophilia, is caused by missing or defective factor VIII. Most individuals, roughly 85%, have hemophilia A and produce too little or no factor VIII. On the other hand, hemophilia B, which is also called Christmas disease, is caused by a deficiency of factor IX.
The report covers the present scenario and the growth prospects of the hemophilia gene therapy. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The report also includes a discussion of the key companies operating in this market.
Major companies uniQure Alnylam Pharmaceuticals BioMarin Pharmaceutical Spark Therapeutics Shire
Research Hemophilia Gene Therapy - A Pipeline Analysis Report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects during the forecast period.
Key questions answered in this report
How will the market evolve during the forecast period? What are the major parameters impacting the market? What are the key market trends? What are the challenges to market growth? Who are the key companies in this market space? You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Companies Mentioned:
uniQure, Alnylam Pharmaceuticals, BioMarin Pharmaceutical, Spark Therapeutics, and Shire.
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
